Introducing Mainz BioMed with Guido Baechler

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/66/d0/b8/66d0b8e0-dc79-45ef-0087-19a7552199d0/mza_17778760957077594521.jpg/600x600bb.jpg

Dear Retail Investors

14 episodes

5 days ago

Created by retail investors like you, this podcast advocates for, educates, and enriches small-cap retail investors who are in a hidden corner of the stock market.

Investing

Business

RSS

All content for Dear Retail Investors is the property of Dear Retail Investors and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Created by retail investors like you, this podcast advocates for, educates, and enriches small-cap retail investors who are in a hidden corner of the stock market.

Investing

Business

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_episode400/17203442/17203442-1636152228955-1b6ca93739ac4.jpg

Introducing Mainz BioMed with Guido Baechler

Dear Retail Investors

18 minutes 57 seconds

4 years ago

Introducing Mainz BioMed with Guido Baechler

We spoke with Guido Baechler, CEO & Director of Mainz BioMed, a newly listed company (NASDAQ : MYNZ) behind the breakthrough product Colo Alert, an early-detection cancer screening tool. Guido discusses his background in biotech, the talented team at Mainz driving their success, and the road to FDA approval for a product already approved and commercially distributed throughout the EU.

Dylan Berg Founder, Dear Retail

Twitter: @Dylan_berg

www.dearretailinvestors.com

Guido Baechler CEO & Director, Mainz BioMed

mainzbiomed.com

Nasdaq: MYNZ